Try our Advanced Search for more refined results
MALLINCKRODT INC. V. WATSON LABORATORIES, INC.-FLORIDA
Case Number:
2:10-cv-06424
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 25, 2012
Covidien Makes Deal With Watson To Allow Generic Exalgo
Zalicus Inc. on Wednesday said Covidien PLC, with which it partners on Covidien's painkiller Exalgo, has agreed to a settlement with Watson Pharmaceuticals Inc. that will allow a generic version of Exalgo to hit the market before the expiration of Covidien's patent.
-
December 15, 2010
Covidien Unit Targets Watson Over Generic Exalgo
A Covidien PLC subsidiary has sued specialty pharmaceutical company Watson Pharmaceuticals Inc. in an effort to stop it from marketing a generic version of painkiller Exalgo.